COMPANY
PQ Pharmacy, LLC
PQ Pharmacy, LLC: 503B outsourcing facility, warning letter recipient for Semaglutide, as stated by public registers.
Also written as: PQ Pharmacy LLC.
503B OUTSOURCING FACILITY
Registered with FDA as a 503B outsourcing facility (compounding at scale).
| All products | Brooksville, FL, registered 2020-10-29 Regulator FDA 503B facility list |
|---|
WARNING LETTER RECIPIENT
Received an FDA warning letter naming the peptide.
| Semaglutide | Compounding Pharmacy/Adulterated Drug Products, 2025-10-10 Regulator FDA warning letters |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.